Financial News Feed

Stronger Sell Today CANF ranks #4928 as SELL CANDIDATE. Weaker Sell
Today CANF ranks #4928 as SELL CANDIDATE.

CANF stock Can-Fite BioPharma Ltd

CANF stock
Can-Fite BioPharma Ltd

An important idea when dealing with technical analysis is that historical stock price movements tend to repeat. Technical analysis focuses on chart patterns with the goal of analyzing market movements...

Read more

Amateur investors can sometimes become overwhelmed by the speed and volatility of the stock market. Often times, avoiding big mistakes early on can be the difference between staying in the game or bei...

Read more

CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) was the recipient of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 278,045 shares, a decrea...

Read more

CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) was the recipient of a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 278,045 shares, a de...

Read more

The stock of Can-fite Biopharma Ltd Sponsored Adr (israel (NYSEAMERICAN:CANF) registered a decrease of 3.14% in short interest. CANF's total short interest was...

Read more

The stock of Can-fite Biopharma Ltd Sponsored Adr (israel (NYSEAMERICAN:CANF) registered a decrease of 3.14% in short interest. CANF's total short interest was...

Read more

After a recent spot-check, Can-Fite BioPharma Ltd. (:CANF)’s ATR is 0.09. The Average True Range (ATR) is a measure of stock volatility. The Average True Range is an exponential moving average (14-d...

Read more

Every individual investor strives to make the best possible stock investment decisions. New investors may have a limited knowledge of how the stock market functions. Studying the basics and accumulati...

Read more

CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) was the target of a large decline in short interest in December. As of December 14th, there was short interest totalling 342,908 shares, a decline of 46.7% from t...

Read more

CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) saw a significant decrease in short interest in the month of December. As of December 14th, there was short interest totalling 342,908 shares, a decrease of 46.7%...

Read more

Tracking historical levels on shares of Can-Fite BioPharma Ltd. (:CANF), we can see that the stock has seen a price decline over the last 52-week period. In the last year, shares have shed -33.44%. In...

Read more

The stock of Can-fite Biopharma Ltd Sponsored Adr (israel (NYSEAMERICAN:CANF) registered a decrease of 3.14% in short interest. CANF’s total short interest was 345,700 shares in December as publishe...

Read more

The stock of Can-fite Biopharma Ltd Sponsored Adr (israel (NYSEAMERICAN:CANF) registered a decrease of 3.14% in short interest. CANF's total short interest was...

Read more

Equities analysts expect that Can-Fite Biopharma Ltd (NASDAQ:CANF) will post earnings per share (EPS) of ($0.04) for the current quarter, according to Zacks. Zero analysts have made estimates for Can-...

Read more

Analysts expect that Can-Fite Biopharma Ltd (NASDAQ:CANF) will announce earnings per share of ($0.04) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provide...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank